Regression of inflammatory myofibroblastic tumor of the gastrointestinal tract under infliximab treatment

Dig Dis Sci. 2005 Feb;50(2):262-5. doi: 10.1007/s10620-005-1593-1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Ileal Neoplasms / diagnostic imaging
  • Ileal Neoplasms / drug therapy*
  • Ileocecal Valve*
  • Infliximab
  • Male
  • Remission Induction
  • Tomography, X-Ray Computed

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab